Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation

NCT07397351 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Aroxxen

Sponsor

Research Institute of Geroprotective Technologies